Short Interest in Novozymes A/S (OTCMKTS:NVZMY) Drops By 20.1%

Novozymes A/S (OTCMKTS:NVZMY) saw a significant decrease in short interest during the month of February. As of February 27th, there was short interest totaling 4,463 shares, a decrease of 20.1% from the February 12th total of 5,586 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 305,495 shares, the short-interest ratio is presently 0.0 days. Based on an average daily volume of 305,495 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the shares of the stock are sold short.

Novozymes A/S Price Performance

Shares of NVZMY stock traded up $0.06 during mid-day trading on Monday, reaching $54.57. The stock had a trading volume of 342,908 shares, compared to its average volume of 96,706. The company has a market cap of $22.62 billion, a P/E ratio of 38.98, a price-to-earnings-growth ratio of 0.99 and a beta of 1.11. The company has a current ratio of 1.61, a quick ratio of 1.00 and a debt-to-equity ratio of 0.26. Novozymes A/S has a 12-month low of $53.50 and a 12-month high of $75.99. The business has a 50-day simple moving average of $61.15 and a 200 day simple moving average of $62.00.

Novozymes A/S (OTCMKTS:NVZMY) last issued its quarterly earnings data on Wednesday, February 25th. The biotechnology company reported $0.35 EPS for the quarter, missing analysts’ consensus estimates of $0.79 by ($0.44). Novozymes A/S had a net margin of 13.96% and a return on equity of 6.38%. The business had revenue of $1.18 billion during the quarter, compared to analyst estimates of $1.22 billion. On average, sell-side analysts anticipate that Novozymes A/S will post 1.82 earnings per share for the current year.

Novozymes A/S Company Profile

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).